2013 annual financial data

Capricor Therapeutics 2013 Net margin

Capricor Therapeutics 2013 net margin with verified reported values.

Direct answer

Net margin was -1,766.97%.

Operating income was -6,903,000 USD and net income was -8,892,000 USD.
Operating cash flow was -6,144,000 USD.

Get free Capricor Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
503,233 USD
Operating income
-6,903,000 USD
Net income
-8,892,000 USD
Operating cash flow
-6,144,000 USD